Mihoko Hosoba

965 total citations
14 papers, 750 citations indexed

About

Mihoko Hosoba is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery. According to data from OpenAlex, Mihoko Hosoba has authored 14 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Nephrology and 4 papers in Surgery. Recurrent topics in Mihoko Hosoba's work include Adipokines, Inflammation, and Metabolic Diseases (4 papers), Diabetes Treatment and Management (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Mihoko Hosoba is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (4 papers), Diabetes Treatment and Management (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Mihoko Hosoba collaborates with scholars based in Japan, United States and Canada. Mihoko Hosoba's co-authors include Takuma Narita, Hiroki Fujita, Tsukasa Morii, Masafumi Kakei, Seiki Ito, Hiromi Fujishima, Yuichiro Yamada, Takashi Shimotomai, Jun Koshimura and Takehiro Sato and has published in prestigious journals such as Diabetes Care, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Mihoko Hosoba

14 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mihoko Hosoba Japan 10 343 208 189 174 157 14 750
Motofumi Sasaki Japan 13 334 1.0× 177 0.9× 202 1.1× 87 0.5× 177 1.1× 16 781
Hye Kyoung Song South Korea 17 191 0.6× 139 0.7× 213 1.1× 254 1.5× 144 0.9× 19 894
Nobuo Kajitani Japan 9 340 1.0× 127 0.6× 168 0.9× 87 0.5× 161 1.0× 10 640
Hyun Wha Chung South Korea 9 214 0.6× 139 0.7× 227 1.2× 77 0.4× 128 0.8× 13 574
Ryo Kodera Japan 10 372 1.1× 138 0.7× 170 0.9× 71 0.4× 188 1.2× 16 648
Chenzhong Li China 9 287 0.8× 160 0.8× 174 0.9× 73 0.4× 133 0.8× 20 605
Samy Hadjadj France 16 224 0.7× 168 0.8× 196 1.0× 208 1.2× 96 0.6× 32 808
Maki Murakoshi Japan 18 223 0.7× 369 1.8× 218 1.2× 108 0.6× 109 0.7× 55 905
Tomoya Umezono Japan 17 180 0.5× 239 1.1× 213 1.1× 72 0.4× 78 0.5× 34 681
Harshini Mudaliar Australia 8 286 0.8× 185 0.9× 209 1.1× 67 0.4× 147 0.9× 9 671

Countries citing papers authored by Mihoko Hosoba

Since Specialization
Citations

This map shows the geographic impact of Mihoko Hosoba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihoko Hosoba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihoko Hosoba more than expected).

Fields of papers citing papers by Mihoko Hosoba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihoko Hosoba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihoko Hosoba. The network helps show where Mihoko Hosoba may publish in the future.

Co-authorship network of co-authors of Mihoko Hosoba

This figure shows the co-authorship network connecting the top 25 collaborators of Mihoko Hosoba. A scholar is included among the top collaborators of Mihoko Hosoba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihoko Hosoba. Mihoko Hosoba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fujita, Hiroki, Tsukasa Morii, Hiromi Fujishima, et al.. (2013). The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney International. 85(3). 579–589. 273 indexed citations
2.
Narita, Takuma, Hiroki Yokoyama, Takehiro Sato, et al.. (2011). Comparisons of the effects of 12‐week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients. Diabetes Obesity and Metabolism. 14(3). 283–287. 62 indexed citations
3.
Fujita, Hiroki, Hiromi Fujishima, Tsukasa Morii, et al.. (2011). Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic mice. Hypertension Research. 35(2). 213–220. 43 indexed citations
4.
Sato, Takehiro, Takuma Narita, Mihoko Hosoba, et al.. (2010). A case of insulinoma following total gastrectomy—Effects of an alpha-glucosidase inhibitor on suppressing GIP and GLP-1 elevations. Diabetes Research and Clinical Practice. 88(1). e4–e6. 4 indexed citations
6.
Hosoba, Mihoko, Hiroki Fujita, Toshiyuki Miura, et al.. (2009). Diurnal Changes in Urinary Excretion of IgG, Transferrin, and Ceruloplasmin Depend on Diurnal Changes in Systemic Blood Pressure in Normotensive, Normoalbuminuric Type 2 Diabetic Patients. Hormone and Metabolic Research. 41(12). 910–915. 9 indexed citations
7.
Narita, Takuma, Mihoko Hosoba, Toshiyuki Miura, et al.. (2008). Low Dose of Losartan Decreased Urinary Excretions of IgG, Transferrin, and Ceruloplasmin without Reducing Albuminuria in Normoalbuminuric Type 2 Diabetic Patients. Hormone and Metabolic Research. 40(4). 292–295. 6 indexed citations
8.
Narita, Takuma, Mihoko Hosoba, Masafumi Kakei, & Seiki Ito. (2006). Increased Urinary Excretions of Immunoglobulin G, Ceruloplasmin, and Transferrin Predict Development of Microalbuminuria in Patients With Type 2 Diabetes. Diabetes Care. 29(1). 142–144. 66 indexed citations
9.
Koshimura, Jun, Takuma Narita, Hiroshi Sasaki, et al.. (2005). Urinary Excretion of Transferrin and Orosomucoid Are Increased after Acute Protein Loading in Healthy Subjects. Nephron Clinical Practice. 100(2). c33–c37. 6 indexed citations
10.
Fujita, Hiroki, Hiromi Fujishima, Jun Koshimura, et al.. (2005). Effects of Antidiabetic Treatment with Metformin and Insulin on Serum and Adipose Tissue Adiponectin Levels in db/db Mice. Endocrine Journal. 52(4). 427–433. 48 indexed citations
11.
Shimotomai, Takashi, Masafumi Kakei, Takuma Narita, et al.. (2005). Enhanced Urinary Adiponectin Excretion in IgA-Nephropathy Patients with Proteinuria. Renal Failure. 27(3). 323–328. 18 indexed citations
12.
Shimotomai, Takashi, Masafumi Kakei, Takuma Narita, et al.. (2005). Enhanced Urinary Adiponectin Excretion in IgA-Nephropathy Patients with Proteinuria. Renal Failure. 27(3). 323–328. 38 indexed citations
13.
Koshimura, Jun, Hiroki Fujita, Takuma Narita, et al.. (2004). Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochemical and Biophysical Research Communications. 316(1). 165–169. 99 indexed citations
14.
Narita, Takuma, Hiroshi Sasaki, Mihoko Hosoba, et al.. (2004). Parallel Increase in Urinary Excretion Rates of Immunoglobulin G, Ceruloplasmin, Transferrin, and Orosomucoid in Normoalbuminuric Type 2 Diabetic Patients. Diabetes Care. 27(5). 1176–1181. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026